Pricing law jeopardizes post-approval R&D process for cancer pills: analysis

Pricing law jeopardizes post-approval R&D process for cancer pills: analysis

Source: 
Medical Marketing and Media
snippet: 

The Inflation Reduction Act may disrupt a substantial amount of investment into finding new uses for already approved oncology drugs, researchers say.